Mortality in patients receiving renal replacement therapy in South Korea
Kidney Research and Clinical Practice · 01.05.2026 · 45 (3) · 404-415
DOI: 10.23876/j.krcp.24.035 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kidney Research and Clinical Practice, erschienen am 01.05.2026. Verfasst von BeongWoo Kim und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Inje University Busan Paik Hospital, Busan, Republic of Korea. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
This study analyzed data from the end-stage renal disease patient registry collected by the Korean Society of Nephrology to explore trends in mortality among dialysis patients from 2001 to 2022.
Methods
Mortality was analyzed in two ways: firstly, using the annual mortality rate; and secondly, by assessing survivability after a certain period of time since the initiation of dialysis. Additionally, we categorized the causes of death by disease group annually to observe how the proportions changed.
Results
Since 2001, annual mortality for dialysis patients generally declined, except for a rise in 2020 and 2021 among hemodialysis patients. Overall mortality rates for all dialysis patients dropped from 74.2/1,000 person-years in 2001 to 42.3/1,000 person-years in 2022, with a more pronounced decrease in peritoneal dialysis. While survival probability over the 5 years following initiation of dialysis has shown a steady increase, short-term mortality from 2018 to 2020 affected by coronavirus disease 2019 (COVID-19) has shown a yearly increase by age group, with a greater effect in those aged 75 years and older. The leading causes of death for all dialysis patients have changed little, in the order of heart disease, infection, and vascular problems.
Conclusion
While annual mortality and survival probability after dialysis initiation have generally improved in dialysis patients, there has been a temporary deterioration during the COVID-19 pandemic, most pronounced in the elderly.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Inje University Busan Paik Hospital, Busan, Republic of Korea.
- Department of Internal Medicine, Geoboong Baik Medical Center, Geoje, Republic of Korea.
- Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
- Department of Internal Medicine, The Catholic University of Korea, St Vincent's Hospital, Seoul, Republic of Korea.
- Department of Internal Medicine, Daejeon Eulji Medical Center, Eulji University, Daejeon, Republic of Korea.
- Department of Internal Medicine, Inha University College of Medicine, Incheon, Republic of Korea.
Zitieren
APA
Kim, B., Park, C. I., Hong, Y. A., Yoon, H. E., Kim, Y. K., Kim, H., Kim, K. M., Hwang, S. D., Choi, S. R., Lee, H., Kim, J. H., Kim, S. H., Koo, H. S., Yoon, C. Y., Kim, K., Ahn, S. H., Jeong, S. A., & Kim, T. H. (2026). Mortality in patients receiving renal replacement therapy in South Korea. Kidney Research and Clinical Practice, 45(3), 404-415. https://doi.org/10.23876/j.krcp.24.035
Vancouver
Kim B, Park CI, Hong YA, Yoon HE, Kim YK, Kim H, et al. Mortality in patients receiving renal replacement therapy in South Korea. Kidney Research and Clinical Practice. 2026;45(3):404-415. doi:10.23876/j.krcp.24.035
BibTeX
@article{Kim2026,
author = {Kim, BeongWoo and Park, Chan Il and Hong, Yu Ah and Yoon, Hye Eun and Kim, Yong Kyun and Kim, Hyunglae and Kim, Kyeong Min and Hwang, Seun Deuk and Choi, Sun Ryoung and Lee, Hajeong and Kim, Ji Hyun and Kim, Su Hyun and Koo, Ho-Seok and Yoon, Chang-Yun and Kim, Kiwon and Ahn, Seon Ho and Jeong, Seon A and Kim, Tae Hee},
title = {Mortality in patients receiving renal replacement therapy in South Korea},
journal = {Kidney Research and Clinical Practice},
year = {2026},
volume = {45},
number = {3},
pages = {404--415},
doi = {10.23876/j.krcp.24.035}
}
EUVIMED